Perceptive Advisors as of Sept. 30, 2019
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 108 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Neurocrine Biosciences (NBIX) | 10.6 | $366M | 4.1M | 90.11 | |
| Global Blood Therapeutics In | 8.2 | $285M | 5.9M | 48.52 | |
| Iovance Biotherapeutics (IOVA) | 5.8 | $201M | 11M | 18.20 | |
| Amicus Therapeutics (FOLD) | 5.7 | $197M | 25M | 8.02 | |
| Bridgebio Pharma (BBIO) | 4.2 | $144M | 6.7M | 21.47 | |
| Zogenix | 3.8 | $131M | 3.3M | 40.04 | |
| Athenex | 3.8 | $131M | 11M | 12.16 | |
| Amarin Corporation (AMRN) | 3.4 | $116M | 7.6M | 15.16 | |
| Dova Pharmaceuticals | 3.0 | $104M | 3.7M | 27.95 | |
| Meiragtx Holdings (MGTX) | 3.0 | $103M | 6.4M | 15.95 | |
| Quotient | 2.4 | $84M | 11M | 7.77 | |
| Nevro (NVRO) | 2.4 | $84M | 975k | 85.97 | |
| Solid Biosciences | 2.0 | $70M | 6.7M | 10.34 | |
| Springworks Therapeutics (SWTX) | 2.0 | $70M | 3.2M | 21.68 | |
| Blueprint Medicines (BPMC) | 1.9 | $65M | 883k | 73.47 | |
| Zymeworks | 1.7 | $59M | 2.4M | 24.80 | |
| Myokardia | 1.7 | $59M | 1.1M | 52.15 | |
| Adma Biologics (ADMA) | 1.5 | $51M | 12M | 4.45 | |
| Verrica Pharmaceuticals (VRCA) | 1.5 | $50M | 3.4M | 14.76 | |
| Neptune Wellness Solutions I | 1.4 | $48M | 13M | 3.56 | |
| Vbi Vaccines | 1.3 | $46M | 46M | 1.00 | |
| Kodiak Sciences (KOD) | 1.3 | $45M | 3.1M | 14.38 | |
| Arena Pharmaceuticals | 1.3 | $44M | 953k | 45.77 | |
| Allogene Therapeutics (ALLO) | 1.2 | $42M | 1.5M | 27.25 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.1 | $39M | 2.6M | 15.04 | |
| Retrophin | 1.1 | $38M | 3.3M | 11.59 | |
| Momenta Pharmaceuticals | 1.1 | $38M | 2.9M | 12.96 | |
| Albireo Pharma | 1.0 | $34M | 1.7M | 20.00 | |
| Foamix Pharmaceuticals | 1.0 | $34M | 11M | 3.04 | |
| Spark Therapeutics | 1.0 | $34M | 350k | 96.98 | |
| Kadmon Hldgs | 1.0 | $33M | 13M | 2.52 | |
| Dbv Technologies S A | 0.9 | $31M | 3.6M | 8.60 | |
| Protagonist Therapeutics | 0.7 | $25M | 2.1M | 12.01 | |
| Eidos Therapeutics | 0.7 | $25M | 687k | 35.97 | |
| Cytomx Therapeutics (CTMX) | 0.7 | $24M | 3.3M | 7.38 | |
| Establishment Labs Holdings Ord (ESTA) | 0.7 | $24M | 1.3M | 18.91 | |
| Invitae (NVTAQ) | 0.7 | $23M | 1.2M | 19.27 | |
| Rocket Pharmaceuticals (RCKT) | 0.7 | $23M | 2.0M | 11.65 | |
| Turning Point Therapeutics I | 0.7 | $23M | 597k | 37.60 | |
| Y Mabs Therapeutics (YMAB) | 0.6 | $22M | 855k | 26.06 | |
| Bio-Rad Laboratories (BIO) | 0.6 | $22M | 65k | 332.74 | |
| Regenxbio Inc equity us cm (RGNX) | 0.6 | $22M | 608k | 35.60 | |
| Urovant Sciences | 0.6 | $21M | 2.2M | 9.47 | |
| eHealth (EHTH) | 0.5 | $17M | 255k | 66.79 | |
| Vapotherm | 0.5 | $17M | 1.8M | 9.47 | |
| Merit Medical Systems (MMSI) | 0.5 | $16M | 529k | 30.46 | |
| Aldeyra Therapeutics (ALDX) | 0.5 | $16M | 3.1M | 5.27 | |
| Stoke Therapeutics (STOK) | 0.4 | $14M | 672k | 21.49 | |
| Molecular Templates | 0.4 | $13M | 2.0M | 6.59 | |
| Concert Pharmaceuticals I equity | 0.4 | $13M | 2.2M | 5.88 | |
| Agile Therapeutics | 0.4 | $13M | 11M | 1.18 | |
| Morphic Hldg (MORF) | 0.3 | $12M | 650k | 18.11 | |
| 10x Genomics Inc Cl A (TXG) | 0.3 | $11M | 220k | 50.40 | |
| Marker Therapeutics Ord | 0.3 | $10M | 2.0M | 5.11 | |
| Sc Health Corp unit 99/99/9999 | 0.3 | $10M | 1.0M | 10.35 | |
| Ideaya Biosciences (IDYA) | 0.3 | $9.6M | 1.1M | 8.40 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.3 | $9.1M | 295k | 30.90 | |
| Motus Gi Hldgs Incorporated | 0.2 | $8.3M | 4.2M | 1.98 | |
| Cymabay Therapeutics | 0.2 | $7.8M | 1.5M | 5.12 | |
| Mei Pharma | 0.2 | $7.4M | 4.4M | 1.68 | |
| Viewray (VRAYQ) | 0.2 | $7.1M | 2.5M | 2.90 | |
| Alector (ALEC) | 0.2 | $7.4M | 512k | 14.42 | |
| Teladoc note 1.375 5/1 | 0.2 | $7.4M | 5.0M | 1.48 | |
| Zimmer Holdings (ZBH) | 0.2 | $6.9M | 50k | 137.28 | |
| Intercept Pharmaceuticals In | 0.2 | $6.5M | 98k | 66.36 | |
| Aquestive Therapeutics | 0.2 | $6.7M | 2.1M | 3.18 | |
| Health Catalyst (HCAT) | 0.2 | $6.7M | 211k | 31.64 | |
| Orchard Therapeutics Plc ads | 0.2 | $6.2M | 522k | 11.88 | |
| Select Interior Concepts cl a | 0.2 | $5.7M | 440k | 12.97 | |
| Mirati Therapeutics | 0.1 | $5.0M | 3.4M | 1.45 | |
| Cerner Corporation | 0.1 | $4.4M | 65k | 68.17 | |
| Provention Bio | 0.1 | $4.6M | 666k | 6.83 | |
| Alphatec Holdings (ATEC) | 0.1 | $4.3M | 850k | 5.02 | |
| Translate Bio | 0.1 | $4.3M | 435k | 9.91 | |
| Health Sciences Acqustn Corp unit 04/01/2024 | 0.1 | $4.3M | 400k | 10.73 | |
| Fulcrum Therapeutics (FULC) | 0.1 | $4.0M | 600k | 6.64 | |
| Acasti Pharma | 0.1 | $3.4M | 1.8M | 1.89 | |
| Female Health (VERU) | 0.1 | $3.6M | 1.7M | 2.16 | |
| Twist Bioscience Corp (TWST) | 0.1 | $3.5M | 146k | 23.88 | |
| Beigene (BGNE) | 0.1 | $2.7M | 400k | 6.74 | |
| Vocera Communications | 0.1 | $2.5M | 100k | 24.65 | |
| Correvio Pharma Corp | 0.1 | $2.0M | 1.0M | 2.00 | |
| SPDR S&P Biotech (XBI) | 0.1 | $1.6M | 900k | 1.78 | |
| Seattle Genetics | 0.0 | $1.5M | 17k | 85.41 | |
| CryoLife (AORT) | 0.0 | $1.4M | 50k | 27.16 | |
| Eiger Biopharmaceuticals | 0.0 | $1.4M | 140k | 10.24 | |
| Medicines Company | 0.0 | $977k | 20k | 50.02 | |
| Ferrari Nv Ord (RACE) | 0.0 | $955k | 6.2k | 154.03 | |
| Axsome Therapeutics (AXSM) | 0.0 | $1.1M | 54k | 20.25 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.0 | $866k | 31k | 28.17 | |
| Sierra Oncology | 0.0 | $1.0M | 2.7M | 0.39 | |
| BioMarin Pharmaceutical (BMRN) | 0.0 | $750k | 200k | 3.75 | |
| Karyopharm Therapeutics (KPTI) | 0.0 | $526k | 55k | 9.63 | |
| Zynerba Pharmaceuticals | 0.0 | $636k | 200k | 3.18 | |
| Novocure Ltd ord (NVCR) | 0.0 | $710k | 9.5k | 74.82 | |
| Medpace Hldgs (MEDP) | 0.0 | $532k | 6.3k | 84.07 | |
| Allena Pharmaceuticals | 0.0 | $521k | 132k | 3.94 | |
| Fiat Chrysler Automobiles N | 0.0 | $802k | 62k | 12.94 | |
| Mereo Biopharma Group Plc ads (MREO) | 0.0 | $535k | 179k | 2.98 | |
| Natera (NTRA) | 0.0 | $477k | 15k | 32.79 | |
| Ra Pharmaceuticals | 0.0 | $342k | 15k | 23.66 | |
| G1 Therapeutics | 0.0 | $358k | 16k | 22.80 | |
| Tandem Diabetes Care (TNDM) | 0.0 | $379k | 6.4k | 59.02 | |
| Allakos (ALLK) | 0.0 | $507k | 6.4k | 78.68 | |
| Arqule | 0.0 | $391k | 55k | 7.17 | |
| Abeona Therapeutics Inc *w exp 12/19/201 | 0.0 | $145k | 660k | 0.22 | |
| Conformis | 0.0 | $93k | 50k | 1.86 | |
| Outlook Therapeutics Inc *w exp 02/18/201 | 0.0 | $46k | 421k | 0.11 |
